For people with gambling disorder, the proliferation of gambling opportunities makes it difficult to fight their addiction. Investment in treatment lags behind other addiction disorders.
Mia Love, the first Black Republican woman elected to Congress, died three years after being diagnosed with glioblastoma, a brain cancer that is nearly always fatal.
Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop Wednesday. That has left many patients wondering what to do next.
Dr. Jay Bhattacharya, a Stanford professor of health policy, appears before the Senate HELP committee, which will vet his nomination to become the next director of the National Institutes of Health.
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss medicines it mailed to patients.
There's widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and at institutions dependent on the agency's funding.
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.
